Showing results (201-210 of 801) with videos related to
Sort By:
Pageof 81
Melanoma Research|December 1, 1993
Loss of heterozygosity of the thyroid hormone receptor B in posterior uveal melanomaK Sisley, D Curtis, I G Rennie, et al.Organic & Biomolecular Chemistry|January 8, 2016
Design and synthesis of dihydroisoquinolones for fragment-based drug discovery (FBDD)Nick Palmer, Torren M Peakman, David Norton, et al.Clinical and Experimental Immunology|March 1, 1986
Suppression of natural and activated human antitumour cytotoxicity by human seminal plasmaR C Rees, P Vallely, A Clegg, et al.The Cochrane Database of Systematic Reviews|May 1, 2015
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleedingAnne Lethaby, Munawar Hussain, Josephine R Rishworth, et al.European Journal of Cancer & Clinical Oncology|September 1, 1987
Immunomodulation of natural killer activity in children with acute lymphoblastic leukaemiaA Jermy, R Jennings, J S Lilleyman, et al.Thrombosis and Haemostasis|April 30, 1986
Identification of t-PA as the major active plasminogen activator in human milkJ M Marshall, M C Rees, S A Cederholm-WilliamsScientific Reports|October 3, 2018
Elucidating a role for the cytoplasmic domain in the Mycobacterium tuberculosis mechanosensitive channel of large conductanceNadia Herrera, Grigory Maksaev, Elizabeth S Haswell, et al.Biophysical Journal|April 2, 2003
Open-state disulfide crosslinking between Mycobacterium tuberculosis mechanosensitive channel subunitsGeorge Shapovalov, Randal Bass, Douglas C Rees, et al.Science (New York, N.Y.)|November 26, 2002
Crystal structure of Escherichia coli MscS, a voltage-modulated and mechanosensitive channelRandal B Bass, Pavel Strop, Margaret Barclay, et al.RSC Medicinal Chemistry|December 23, 2022
Introduction to the themed collection on fragment-based drug discoveryDavid C Rees, Anna K H Hirsch, Daniel A ErlansonPageof 81